A phase 2 randomised study of ramucirumab (IMC-1121B) with or without dacarbazine in patients with metastatic melanoma
Titel:
A phase 2 randomised study of ramucirumab (IMC-1121B) with or without dacarbazine in patients with metastatic melanoma
Auteur:
Carvajal, Richard D. Wong, Michael K. Thompson, John A. Gordon, Michael S. Lewis, Karl D. Pavlick, Anna C. Wolchok, Jedd D. Rojas, Patrick B. Schwartz, Jonathan D. Bedikian, Agop Y.